Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 391 | 380 | 430 | 370 | 400 |
| Marketable Securities | 1,217 | 1,110 | 1,090 | 1,070 | 1,060 |
| Other current assets | 0 | 290 | 130 | 170 | 180 |
| TOTAL | $1,799 | $1,780 | $1,650 | $1,610 | $1,640 |
| Non-Current Assets | |||||
| Investments And Advances | 6 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 100 | 116 | 235 | 340 | 390 |
| TOTAL | $105 | $116 | $235 | $340 | $390 |
| Total Assets | $1,904 | $1,900 | $1,890 | $1,970 | $2,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 487 | 290 | 260 | 290 | 320 |
| Other current liabilities | N/A | 90 | 130 | 130 | 130 |
| TOTAL | $561 | $390 | $390 | $420 | $450 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $561 | $390 | $390 | $420 | $450 |
| Shareholders' Equity | |||||
| Retained earnings | -2,958 | -2,890 | -2,900 | -2,890 | -2,850 |
| Other shareholders' equity | -108 | -10 | -10 | -30 | -90 |
| TOTAL | $1,344 | $1,510 | $1,500 | $1,540 | $1,580 |
| Total Liabilities And Equity | $1,904 | $1,900 | $1,890 | $1,960 | $2,030 |